{"id":577,"date":"2018-11-05T13:57:25","date_gmt":"2018-11-05T13:57:25","guid":{"rendered":"http:\/\/www.irlab.se\/corporate-governance\/board-of-directors\/"},"modified":"2026-09-30T09:42:42","modified_gmt":"2026-09-30T07:42:42","slug":"board-of-directors","status":"publish","type":"page","link":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","title":{"rendered":"Styrelse"},"content":{"rendered":"\n<h1 id=\"styrelse\" class=\"wp-block-heading\">Styrelse<\/h1>\n\n\n\n<p class=\"is-style-intro-text-style wp-block-paragraph\">Enligt IRLABs bolagsordning skall styrelsen best\u00e5 av l\u00e4gst tre och h\u00f6gst tio styrelseledam\u00f6ter. Styrelsen best\u00e5r f\u00f6r n\u00e4rvarande av fem styrelseledam\u00f6ter som valdes vid \u00e5rsst\u00e4mman den 30 juni 2026, f\u00f6r tiden intill slutet av \u00e5rsst\u00e4mman 2027. En \u00f6versikt av styrelseledam\u00f6terna \u00e5terfinns i tabellen nedan och en presentation av varje ledamot finns l\u00e4ngre ned.<\/p>\n\n\n\n<table id=\"tablepress-3\" class=\"tablepress tablepress-id-3\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Namn<\/th><th class=\"column-2\">Befattning i styrelse<\/th><th class=\"column-3\">Revisionsutskott<\/th><th class=\"column-4\">Ers\u00e4ttningsutskott<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Janne Backman<\/td><td class=\"column-2\">Ordf\u00f6rande<\/td><td class=\"column-3\"><\/td><td class=\"column-4\">Ordf\u00f6rande<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">James Gamgort <\/td><td class=\"column-2\">Ledamot<\/td><td class=\"column-3\"><\/td><td class=\"column-4\"><\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Gunnar Olsson<\/td><td class=\"column-2\">Vice ordf\u00f6rande<\/td><td class=\"column-3\"><\/td><td class=\"column-4\">Ledamot<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">Rein Piir<\/td><td class=\"column-2\">Ledamot<\/td><td class=\"column-3\">Ledamot<\/td><td class=\"column-4\"><\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Veronica Wallin<\/td><td class=\"column-2\">Ledamot<\/td><td class=\"column-3\">Ordf\u00f6rande<\/td><td class=\"column-4\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-3 from cache -->\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"761\" height=\"1024\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/Janne-Backman.png\" alt=\"\" class=\"wp-image-13216\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/Janne-Backman.png 761w, https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/Janne-Backman-223x300.png 223w\" sizes=\"auto, (max-width: 761px) 100vw, 761px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Janne Backman<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ordf\u00f6rande f\u00f6dd 1981<br>Invald i styrelsen 2026<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"wp-block-paragraph\"><em>Utbildning och bakgrund:<\/em>&nbsp; Kandidatexamen i f\u00f6retagsekonomi och IT fr\u00e5n H\u00f6gskolan i Bor\u00e5s samt en magisterexamen i f\u00f6retagsekonomi fr\u00e5n G\u00f6teborgs universitet. Mer \u00e4n 20 \u00e5rs erfarenhet fr\u00e5n Life science-industrin. Innehaft positioner som Senior Global Strategy and Marketing Director, Global Strategy and Marketing Director och Global Program Director inom FoU vid The Medicines Company d\u00e4r han ledde internationella kommersialiseringsstrategier, EU-produktlanseringar och globala utvecklingsprogram. D\u00e4rut\u00f6ver har han haft kommersiella befattningar vid Merck Serono och AstraZeneca. Sedan 2016 vd f\u00f6r J.F.B Consulting AB och J.F.B Invest.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>P\u00e5g\u00e5ende uppdrag<\/em>: Styrelseordf\u00f6rande i&nbsp;Sobrera Pharma AB<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Aktieinnehav<\/em>: 541 688 A-aktier, 1 000 000 teckningsoptioner av serie 2026\/2029:1.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare<\/em><\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"761\" height=\"1024\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/james-gamgort.png\" alt=\"\" class=\"wp-image-13325\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/james-gamgort.png 761w, https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/james-gamgort-223x300.png 223w\" sizes=\"auto, (max-width: 761px) 100vw, 761px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">James Gamgort<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">F\u00f6dd 1967<br>Invald i styrelsen 2026<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"wp-block-paragraph\"><em>Utbildning och bakgrund:<\/em>&nbsp; Kandidatexamen i nationalekonomi fr\u00e5n Hobart and William Smith Colleges i New York samt l\u00e4st nationalekonomi vid Franklin University of Switzerland.&nbsp;Mer \u00e4n 25 \u00e5rs erfarenhet fr\u00e5n l\u00e4kemedels- och medicinteknisk industri med focus p\u00e5 kommersialiseringsstrategi, globala produktlanseringar, marknadsf\u00f6ring och aff\u00e4rsutveckling p\u00e5 s\u00e5v\u00e4l den amerikanska som den internationella marknaden d\u00e4ribland Johnson &amp; Johnson, Merck, The Medicines Company och Alcresta Therapeutics. F\u00f6r n\u00e4rvarande Managing Partner och Chief Commercial Officer p\u00e5 Encompass Communications and Learning Inc.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>P\u00e5g\u00e5ende uppdrag:<\/em>&nbsp;Styrelseledamot i&nbsp;Sobrera Pharma AB<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Aktieinnehav:<\/em>&nbsp;210 500 A-aktier.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare.<\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"761\" height=\"1024\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Gunnar_Olsson_IRLAB_WEB_761_1084.jpg\" alt=\"\" class=\"wp-image-8880\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Gunnar_Olsson_IRLAB_WEB_761_1084.jpg 761w, https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Gunnar_Olsson_IRLAB_WEB_761_1084-223x300.jpg 223w\" sizes=\"auto, (max-width: 761px) 100vw, 761px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Gunnar Olsson<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vice ordf\u00f6rande f\u00f6dd 1953<br>Invald i styrelsen 2017<br><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"wp-block-paragraph\"><em>Utbildning och bakgrund<\/em>: MD, PhD, docent vid Karolinska Institutet, medicine hedersdoktor vid G\u00f6teborgs Universitet. Adjungerad professor vid Karolinska Institutet 1998-2010. Mer \u00e4n 35 \u00e5rs erfarenhet inom life science f\u00f6retag. Innehaft ledande befattningar inom AstraZeneca under 25 \u00e5r, varav 10 \u00e5r som ledare f\u00f6r terapiomr\u00e5dena Cardiovascular and Gastro-intestinal inom Global R&amp;D. Varit ansvarig f\u00f6r utveckling av sju globala blockbusters\/mega-l\u00e4kemedel. Sedan 2013 innehaft styrelse- och konsult uppdrag i bio-tech f\u00f6retag sprungna ur svensk akademisk forskning. VD i IRLAB 2023-2024.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>P\u00e5g\u00e5ende uppdrag<\/em>: Vice styrelseordf\u00f6rande i Hj\u00e4rt och Lungfonden Svenska Nationalf\u00f6reningen mot hj\u00e4rt och lungsjukdomar och i Bundy Academy vid Lunds universitet. Styrelseledamot i Amplifier Tx AB, Betagenon AB, Betagenon Bio AB, Cereno Scientific AB och Olsson Solutions AB. Bolagsman i Olsson Solutions Kommanditbolag.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Aktieinnehav<\/em>: 32 500 A-aktier, 65 000 teckningsoptioner av serie 2026\/2029:1.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare.<\/em><\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"761\" height=\"1024\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Rein_Piir_IRLAB_WEB_761_1084.jpg\" alt=\"\" class=\"wp-image-8894\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Rein_Piir_IRLAB_WEB_761_1084.jpg 761w, https:\/\/irlab.se\/wp-content\/uploads\/2022\/04\/Rein_Piir_IRLAB_WEB_761_1084-223x300.jpg 223w\" sizes=\"auto, (max-width: 761px) 100vw, 761px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Rein Piir<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">f\u00f6dd 1958<br>Invald i styrelsen 2016<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"wp-block-paragraph\"><em>Utbildning och bakgrund: <\/em>Civilekonom med BSc i F\u00f6retagsekonomi och ledning vid Uppsala universitet.&nbsp;35 \u00e5rs erfarenhet av r\u00e5dgivning inom kapitalmarknadsfr\u00e5gor och finansiering. Innehaft positioner som analyschef p\u00e5 Carnegie Investment Bank, strateg Alecta, CFO\/IR-chef Medivir samt revisor p\u00e5 PricewaterhouseCoopers AB, IR-ansvarig p\u00e5 Oncopeptides AB samt, genom Piir &amp; Partner AB, behj\u00e4lplig med arbetet kring investerarrelationer p\u00e5 Camurus AB.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>P\u00e5g\u00e5ende uppdrag:<\/em> Styrelseordf\u00f6rande i Piir &amp; Partner AB. Styrelseledamot i L. E. Svensson Snickeri Aktiebolag.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Aktieinnehav:<\/em> 98 233 A-aktier och 5 567 B-aktier via bolag\/n\u00e4rst\u00e5ende, 45 000 teckningsoptioner av serie 2026\/2029:1.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare.<\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"315\" height=\"468\" src=\"https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Veronica-Wallin-sv.jpg\" alt=\"\" class=\"wp-image-10862\" srcset=\"https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Veronica-Wallin-sv.jpg 315w, https:\/\/irlab.se\/wp-content\/uploads\/2023\/07\/Veronica-Wallin-sv-202x300.jpg 202w\" sizes=\"auto, (max-width: 315px) 100vw, 315px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Veronica Wallin<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">f\u00f6dd 1986<br>Invald i styrelsen 2023<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"wp-block-paragraph\"><em>Utbildning och bakgrund:<\/em> Magisterexamen i f\u00f6retagsekonomi vid Stockholms universitet. Studier inom marknadsf\u00f6ring, PR, kommunikation och redovisning vid The State University of New York at New Paltz. 10-\u00e5rig erfarenhet inom Life Science, bland annat genom styrelseuppdrag och ledande positioner i bolag inom branschen. Innehaft positioner som styrelseledamot i Alligator Bioscience, CFO p\u00e5 medicinteknikbolaget Episurf Medical AB och apoteksbolaget ApoEx AB samt som revisor p\u00e5 BDO. F\u00f6r n\u00e4rvarande CFO p\u00e5 4C Group AB.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>P\u00e5g\u00e5ende uppdrag:<\/em> Styrelseledamot i Board member of 4C Strategies AB, 4C International AB, 4C Europe UK Limited,  Episurf DE GmbH and Episurf India Limited.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Aktieinnehav:<\/em> 37 832 A-aktier personligen samt via kapitalf\u00f6rs\u00e4kring.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Bed\u00f6ms oberoende i f\u00f6rh\u00e5llande till bolaget, dess ledning och st\u00f6rre aktie\u00e4gare.<\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-sand-color has-css-opacity has-sand-background-color has-background is-style-wide\"\/>\n\n\n\n<div style=\"height:16px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-small-font-size wp-block-paragraph\"><em><em>Eget eller n\u00e4rst\u00e5ende fysisk eller juridisk persons innehav av aktier och andra finansiella instrument i bolaget. Innehav 31 augusti 2026.<\/em><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Styrelse Enligt IRLABs bolagsordning skall styrelsen best\u00e5 av l\u00e4gst tre och h\u00f6gst tio styrelseledam\u00f6ter. Styrelsen best\u00e5r f\u00f6r n\u00e4rvarande av fem styrelseledam\u00f6ter som valdes vid \u00e5rsst\u00e4mman den 30 juni 2026, f\u00f6r tiden intill slutet av \u00e5rsst\u00e4mman 2027. En \u00f6versikt av styrelseledam\u00f6terna \u00e5terfinns i tabellen nedan och en presentation av varje ledamot finns l\u00e4ngre ned. Janne Backman [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":612,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-577","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Styrelse - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Styrelse - IRLAB\" \/>\n<meta property=\"og:description\" content=\"Styrelse Enligt IRLABs bolagsordning skall styrelsen best\u00e5 av l\u00e4gst tre och h\u00f6gst tio styrelseledam\u00f6ter. Styrelsen best\u00e5r f\u00f6r n\u00e4rvarande av fem styrelseledam\u00f6ter som valdes vid \u00e5rsst\u00e4mman den 30 juni 2026, f\u00f6r tiden intill slutet av \u00e5rsst\u00e4mman 2027. En \u00f6versikt av styrelseledam\u00f6terna \u00e5terfinns i tabellen nedan och en presentation av varje ledamot finns l\u00e4ngre ned. Janne Backman [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-30T07:42:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/Janne-Backman.png\" \/>\n\t<meta property=\"og:image:width\" content=\"761\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/board-of-directors\\\/\",\"url\":\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/board-of-directors\\\/\",\"name\":\"Styrelse - IRLAB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/irlab.se\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/irlab.se\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Janne-Backman.png\",\"datePublished\":\"2018-11-05T13:57:25+00:00\",\"dateModified\":\"2026-09-30T07:42:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/irlab.se\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Janne-Backman.png\",\"contentUrl\":\"https:\\\/\\\/irlab.se\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Janne-Backman.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/irlab.se\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Om IRLAB\",\"item\":\"https:\\\/\\\/irlab.se\\\/sv\\\/om-irlab\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Styrelse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/irlab.se\\\/#website\",\"url\":\"https:\\\/\\\/irlab.se\\\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/irlab.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Styrelse - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","og_locale":"sv_SE","og_type":"article","og_title":"Styrelse - IRLAB","og_description":"Styrelse Enligt IRLABs bolagsordning skall styrelsen best\u00e5 av l\u00e4gst tre och h\u00f6gst tio styrelseledam\u00f6ter. Styrelsen best\u00e5r f\u00f6r n\u00e4rvarande av fem styrelseledam\u00f6ter som valdes vid \u00e5rsst\u00e4mman den 30 juni 2026, f\u00f6r tiden intill slutet av \u00e5rsst\u00e4mman 2027. En \u00f6versikt av styrelseledam\u00f6terna \u00e5terfinns i tabellen nedan och en presentation av varje ledamot finns l\u00e4ngre ned. Janne Backman [&hellip;]","og_url":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","og_site_name":"IRLAB","article_modified_time":"2026-09-30T07:42:42+00:00","og_image":[{"width":761,"height":1024,"url":"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/Janne-Backman.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"4 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","url":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/","name":"Styrelse - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/Janne-Backman.png","datePublished":"2018-11-05T13:57:25+00:00","dateModified":"2026-09-30T07:42:42+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#primaryimage","url":"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/Janne-Backman.png","contentUrl":"https:\/\/irlab.se\/wp-content\/uploads\/2026\/06\/Janne-Backman.png"},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/om-irlab\/board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Om IRLAB","item":"https:\/\/irlab.se\/sv\/om-irlab\/"},{"@type":"ListItem","position":3,"name":"Styrelse"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=577"}],"version-history":[{"count":111,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/577\/revisions"}],"predecessor-version":[{"id":13611,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/577\/revisions\/13611"}],"up":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/612"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}